1Arkwright P D, David T J. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease[J]. J Allergy Clin Immunol,2001,107 :531 -534.
2Breivik T, Rook G A. Prevaccination with SRL172(heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in vistar rats[J].clin Exp Immunol,2000,120:463-467.
3Wang C C, Rook G A. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae[J].Immunology, 1998, 93:307-313.
4Hrouda D, Souberbielle B E, Kayaga J, et al. Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancer[J]. Br J Urol, 1998, 82:870 -876.
5Hrouda D,Baban B, Dunsmuir W D, et al. Immunotherapy of advanced prostate cancer: a phase Ⅰ/Ⅱ trial using Mycobacterium vaccae (SRL172) [J]. Br J Urol, 1998, 82:568 -573.
6BrienME, SaniniA, SmithIE, etal. A randomized phase Ⅱ study of SRL172 ( Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma[J]. Br J Cancer, 2000, 83(7): 853-857.
7Balagon M V, Walsh D S, Tan P L, et al. Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae [J]. IntJDermatol, 2000, 39(1): 51 -58.
8Lehrer A, Bressanelli A, Wachsmann V, et al. Immunotherapy with Mycobacterium vaccae in the treatment of psoriasis [J]. FEMS Immunol Med Microbiol, 1998, 21: 71 - 77.
9Skinner M A, Yuan S, Prestidge R, et al. Immunization with heatkilled Mycobacterium vaccae stimulates CD+8 cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis [J]. Infect Innun, 1997, 65(10): 4525 -4530.
10Dlugovitzky D, Bottasso O, Dominino J C, et al. Clinical and serological studies of tuberculosis patients in argentina receiving immunotherapy with Mycobacterium vaccae ( SRL172 ) [J]. Respir Med, 1999, 3:557 - 562.
